Article Details

TROP2 Predictive of Clinical Outcomes in Patients With NCSLC Treated With Datopotamab ...

Retrieved on: 2024-09-10 02:25:21

Tags for this article:

Click the tags to see associated articles and topics

TROP2 Predictive of Clinical Outcomes in Patients With NCSLC Treated With Datopotamab .... View article details on hiswai:

Excerpt

... AstraZeneca's computational pathology platform, can identify which ... AstraZeneca. 1. Dato-DXd is an engineered TROP2-directed antibody drug ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up